TrialESMO open2025

Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial.

E Elez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.